Akar, S. Et Al. 2017. IS THERE ANY ROLE OF IMMUNOGENICITY ON THE RESPONSE TO THE ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE FIRST RESULTS OF A PROSPECTIVE COHORT STUDY. Annual European Congress of Rheumatology , (Madrid, Spain), 354.

Akar, S., Cinar, M., Sargin, G., Karadag, O., Kinikli, G., Ozmen, M., ... Gercik, O.(2017). IS THERE ANY ROLE OF IMMUNOGENICITY ON THE RESPONSE TO THE ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE FIRST RESULTS OF A PROSPECTIVE COHORT STUDY . Annual European Congress of Rheumatology (pp.354). Madrid, Spain

Akar, S. Et Al. "IS THERE ANY ROLE OF IMMUNOGENICITY ON THE RESPONSE TO THE ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE FIRST RESULTS OF A PROSPECTIVE COHORT STUDY," Annual European Congress of Rheumatology, Madrid, Spain, 2017

Akar, S. Et Al. "IS THERE ANY ROLE OF IMMUNOGENICITY ON THE RESPONSE TO THE ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE FIRST RESULTS OF A PROSPECTIVE COHORT STUDY." Annual European Congress of Rheumatology , Madrid, Spain, pp.354, 2017

Akar, S. Et Al. (2017) . "IS THERE ANY ROLE OF IMMUNOGENICITY ON THE RESPONSE TO THE ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE FIRST RESULTS OF A PROSPECTIVE COHORT STUDY." Annual European Congress of Rheumatology , Madrid, Spain, p.354.

@conferencepaper{conferencepaper, author={S. Akar Et Al. }, title={IS THERE ANY ROLE OF IMMUNOGENICITY ON THE RESPONSE TO THE ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE FIRST RESULTS OF A PROSPECTIVE COHORT STUDY}, congress name={Annual European Congress of Rheumatology}, city={Madrid}, country={Spain}, year={2017}, pages={354} }